Towards reliable and transparent vaccine phase III trials with smart contracts

• URL: http://arxiv.org/abs/2102.07022v1
• Date: Sat, 13 Feb 2021 22:38:36 GMT
• Title: Towards reliable and transparent vaccine phase III trials with smart contracts
• Authors: Ivan da Silva Sendin and Rodrigo Sanches Miani
• Abstract summary: This paper proposes a protocol based on Smart Contracts, named VaccSC, to enable transparency, accounting, and confidentiality to Phase III of vaccine experiments. Results show that the VaccSC enables double-blindness, randomization, and the auditability of clinical data, even in the presence of dishonest participants.
• Score: 0.22843885788439797
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: Transforming a vaccine concept into a real vaccine product is a complicated process and includes finding suitable antigens and regulatory, technical, and manufacturing obstacles. A relevant issue within this scope is the clinical trial process. Monitoring and ensuring the integrity of trial data using the traditional system is not always feasible. The search for a vaccine against the coronavirus SARS-CoV-2 illustrates this situation. The scientific credibility of findings from several vaccines' clinical trials contributed to distorted perceptions concerning the benefits and risks of the drug. This scenario is ideal for applying technologies such as Blockchain and Smart Contracts in healthcare issues. This paper proposes a protocol based on Smart Contracts, named VaccSC, to enable transparency, accounting, and confidentiality to Phase III of vaccine experiments. The protocol was implemented in Solidity language, and results show that the VaccSC enables double-blindness, randomization, and the auditability of clinical data, even in the presence of dishonest participants.

Related papers

• Immunogenicity Prediction with Dual Attention Enables Vaccine Target Selection [6.949493332885247]
  ProVaccine is a novel deep learning solution that integrates latent vector representations of protein sequences and structures. We also compile the most comprehensive immunogenicity dataset to date, encompassing over 9,500 antigen sequences, structures, and immunogenicity labels from bacteria, viruses, and tumors. Our work provides an effective tool for vaccine design and sets valuable benchmarks for future research.
  arXiv  Detail & Related papers  (2024-10-03T16:33:35Z)
• TrialBench: Multi-Modal Artificial Intelligence-Ready Clinical Trial Datasets [57.067409211231244]
  This paper presents meticulously curated AIready datasets covering multi-modal data (e.g., drug molecule, disease code, text, categorical/numerical features) and 8 crucial prediction challenges in clinical trial design. We provide basic validation methods for each task to ensure the datasets' usability and reliability. We anticipate that the availability of such open-access datasets will catalyze the development of advanced AI approaches for clinical trial design.
  arXiv  Detail & Related papers  (2024-06-30T09:13:10Z)
• Hierarchical Multi-Label Classification of Online Vaccine Concerns [8.271202196208]
  Vaccine concerns are an ever-evolving target, and can shift quickly as seen during the COVID-19 pandemic. We explore the task of detecting vaccine concerns in online discourse using large language models (LLMs) in a zero-shot setting without the need for expensive training datasets.
  arXiv  Detail & Related papers  (2024-02-01T20:56:07Z)
• Accurate Measures of Vaccination and Concerns of Vaccine Holdouts from Web Search Logs [31.231365080959247]
  We show how large-scale search engine logs and machine learning can be leveraged to fill gaps in vaccine data. We develop a vaccine intent classifier that can accurately detect when a user is seeking the COVID-19 vaccine on search. We use our classifier to identify two groups, vaccine early adopters and vaccine holdouts.
  arXiv  Detail & Related papers  (2023-06-12T23:19:55Z)
• AutoTrial: Prompting Language Models for Clinical Trial Design [53.630479619856516]
  We present a method named AutoTrial to aid the design of clinical eligibility criteria using language models. Experiments on over 70K clinical trials verify that AutoTrial generates high-quality criteria texts.
  arXiv  Detail & Related papers  (2023-05-19T01:04:16Z)
• Dense Feature Memory Augmented Transformers for COVID-19 Vaccination Search Classification [60.49594822215981]
  This paper presents a classification model for detecting COVID-19 vaccination related search queries. We propose a novel approach of considering dense features as memory tokens that the model can attend to. We show that this new modeling approach enables a significant improvement to the Vaccine Search Insights (VSI) task.
  arXiv  Detail & Related papers  (2022-12-16T13:57:41Z)
• Doctors vs. Nurses: Understanding the Great Divide in Vaccine Hesitancy among Healthcare Workers [64.1526243118151]
  We find that doctors are overall more positive toward the COVID-19 vaccines. Doctors are more concerned with the effectiveness of the vaccines over newer variants. Nurses pay more attention to the potential side effects on children.
  arXiv  Detail & Related papers  (2022-09-11T14:22:16Z)
• Constrained Submodular Optimization for Vaccine Design [1.7622426179653559]
  Genetic variability makes it difficult to design peptide vaccines that provide widespread immunity in vaccinated populations. We introduce a framework for evaluating and designing peptide vaccines that uses probabilistic machine learning models. We demonstrate its ability to produce designs for a SARS-CoV-2 vaccine that outperform previous designs.
  arXiv  Detail & Related papers  (2022-06-16T17:40:54Z)
• Vaccine Credential Technology Principles [0.0]
  Digital vaccine certificates could potentially be part of a safe return to work, travel, and daily life. We outline potential implementation and ethical concerns that may arise from tech-enabled vaccine credentialing programs. We suggest a set of principles that, if adopted, may implicated these concerns, forestall preventable harms, and point the way forward.
  arXiv  Detail & Related papers  (2021-05-28T00:18:10Z)
• Predicting Infectiousness for Proactive Contact Tracing [75.62186539860787]
  Large-scale digital contact tracing is a potential solution to resume economic and social activity while minimizing spread of the virus. Various DCT methods have been proposed, each making trade-offs between privacy, mobility restrictions, and public health. This paper develops and test methods that can be deployed to a smartphone to proactively predict an individual's infectiousness.
  arXiv  Detail & Related papers  (2020-10-23T17:06:07Z)
• Falling into the Echo Chamber: the Italian Vaccination Debate on Twitter [65.7192861893042]
  We examine the extent to which the vaccination debate on Twitter is conductive to potential outreach to the vaccination hesitant. We discover that the vaccination skeptics, as well as the advocates, reside in their own distinct "echo chambers" At the center of these echo chambers we find the ardent supporters, for which we build highly accurate network- and content-based classifiers.
  arXiv  Detail & Related papers  (2020-03-26T13:55:50Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.